About Telehealth Sermorelin

What this site is

Telehealth Sermorelin is a plain-English primer on the peer-reviewed research about Sermorelin (GHRH(1-29)). The aim is simple: take the real studies — many of them decades old, dense, and paywalled — and explain what they actually measured in language an ordinary, curious adult can read straight through. The plain-English version leads; the full technical detail sits underneath, every number traced to its source.

A primer explains; it does not treat. Nothing here is diagnosed, prescribed, or compounded for anyone, and no consultation is offered. There is no clinic and no counter behind these pages: sermorelin is neither sold nor supplied, and nothing is for sale. What the primer offers is a reading of published science, honestly labeled.

About the name

The word 'telehealth' in the name is framing, not a service. It signals the questions people ask when they meet sermorelin online — availability, what it does, whether it works — which is the lens the research is organized around. It does not mean consultations, prescriptions, telemedicine, or treatment of any kind happen here. There is no doctor behind the name and no product behind the page. Medical care comes from a licensed clinician who knows your history — not from a website.

How we handle the evidence

A few lines are held strictly. No study, number, or citation is ever invented. No human dose is given and no one is told what to take. When a body-composition figure actually comes from a related analog like tesamorelin rather than from sermorelin itself, that is said plainly rather than let pass as a sermorelin result. And what people report in forums is kept clearly apart from what studies demonstrate. Sermorelin has a real, sometimes-misstated history — once an FDA-approved injectable for childhood growth deficiency, withdrawn in 2008 for business reasons, now a compounded Category 1 substance — and that history is stated straight rather than dressed up.